New CEO Jake Leach said the company plans a trial readout in mid-2026 to support coverage of its glucose sensors in Type 2 users who don’t take insulin.
DexCom expects 2026 total revenue to be in a range of $5.16 billion to $5.25 billion, representing growth of 11% to 13% for the year. Sylvain indicated, "This guidance assumes continued strong ...
Abbott Diabetes Care is recalling certain FreeStyle Libre 3 and FreeStyle Libre 3 Plus sensors due to falsely low glucose readings.
A wearable biosensor developed by Washington State University researchers could improve wireless glucose monitoring for ...
The manufacturer has identified that certain Abiomed heart pumps with differential pressure sensors have the potential to display inaccurate information.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results